Hikal surges on signing multi-year contract with leading agrochemical company
Hikal is currently trading at Rs. 216.40, up by 5.45 points or 2.58% from its previous closing of Rs. 210.95 on the BSE.
The scrip opened at Rs. 213.85 and has touched a high and low of Rs. 218.40 and Rs. 206.90 respectively. So far 16134 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 260.80 on 04-Dec-2025 and a 52 week low of Rs. 145.95 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 223.60 and Rs. 191.50 respectively. The current market cap of the company is Rs. 2685.49 crore.
The promoters holding in the company stood at 68.85%, while Institutions and Non-Institutions held 6.59% and 24.56% respectively.
Hikal has signed a multi-year contract with a Europe-based global agrochemical company to supply a specialised agrochemical product to markets worldwide. The contract, signed by Hikal’s Crop Protection division, covers contract development and manufacturing (CDMO) of the product for which Hikal undertook process development and scale-up. Commercial launch is expected towards the end of FY 2026-27, with volumes anticipated to grow progressively as regulatory approvals are secured across global markets.
The partnership underscores Hikal’s capabilities in process development and commercialisation, demonstrating its ability to translate customer requirements into long-term manufacturing opportunities. It also strengthens Hikal’s Crop Protection business by expanding its portfolio of specialised offerings for global customers. Hikal partners with global companies across pharmaceuticals, crop protection, animal health and specialty chemicals, leveraging its research and development, process chemistry and manufacturing capabilities to support customers from development through commercial production.
